Subconjunctival Bupivacaine in Strabismus Surgery

NCT04782960 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-03-04

No results posted yet for this study

Summary

This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia.

Conditions

  • Anesthesia, Local

Interventions

DRUG

Iocal anaesthetic bupivacaine

Local anaesthetic Subconjunctival bupivacaine

DRUG

Placebo

0.9 saline

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Principal Investigators

  • Mohammad A Hamed, MD · Fayoum University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2021-05-31
Completion
2021-05-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04782960 on ClinicalTrials.gov